Pharmacokinetics of recombinant activated factor VII (rFVIIa).
Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injections.
Recombinant factor VIIa in the treatment of bleeding in hemophilic children with inhibitors.
Prescribing Info - Questions - Drug Info - Links - PDA Software - Article Summaries - Slideshows - Review Articles - What's New
© Copyright 1999-2020 All Rights Reserved.